









市場行情
/
股票
/
nasdaq-flgt
/

Fulgent Genetics Inc

FLGT

18.240USD

-0.290-1.57%

交易中（美東）報價延遲15分鐘

558.29M總市值

虧損本益比TTM



Fulgent Genetics Inc

18.240

-0.290-1.57%

概覽公司財務

Fulgent Genetics, Inc. 是一家技術型基因公司，擁有實驗室服務業務和治療開發業務。該公司的實驗室服務業務包括技術實驗室服務和執業醫師對實驗室結果的專業解釋。其治療開發業務專注於使用納米封裝和靶向治療平臺開發用於治療一系列癌症的候選藥物，旨在改善新舊抗癌藥物的治療窗口和藥代動力學 (PK) 特徵。其實驗室服務業務的技術平臺包括基因探針、數據抑制和比較算法、學習軟件和實驗室信息管理系統。該平臺提供測試菜單、快速開發和啓動新測試的能力以及可定製的測試產品。該公司還提供下一代測序 (NGS) 服務。

公司簡介

公司代碼FLGT

公司名稱Fulgent Genetics Inc

上市日期Sep 28, 2016

CEOMr. Ming Hsieh

員工數量1313

證券類型Ordinary Share

年結日Sep 28

公司地址4399 Santa Anita Ave

城市EL MONTE

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編91731

電話16263500537

網址https://www.fulgentgenetics.com/

公司代碼FLGT

上市日期Sep 28, 2016

CEOMr. Ming Hsieh

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Ming Hsieh

Chairman of the Board, Chief Executive Officer

8.77M

-0.07%

Dr. Hanlin (Harry) Gao, M.D., Ph.D.

Chief Scientific Officer, Laboratory Director

876.30K

-0.19%

Mr. Jian (James) Xie

President, Chief Operating Officer

243.59K

-1.76%

Mr. Paul Kim, CPA

Chief Financial Officer

237.31K

-1.14%

Ms. Linda Marsh

Independent Director

18.11K

+98.39%

Ms. Regina E. (Reggie) Groves

Independent Director

12.23K

+276.37%

Dr. Michael Nohaile, Ph.D.

Independent Director

10.51K

+74.68%

Ms. Melanie Solomon

Investor Relations

名稱

名稱/職務

職務

持股

持股變動

Mr. Ming Hsieh

Chairman of the Board, Chief Executive Officer

8.77M

-0.07%

Dr. Hanlin (Harry) Gao, M.D., Ph.D.

Chief Scientific Officer, Laboratory Director

876.30K

-0.19%

Mr. Jian (James) Xie

President, Chief Operating Officer

243.59K

-1.76%

Mr. Paul Kim, CPA

Chief Financial Officer

237.31K

-1.14%

Ms. Linda Marsh

Independent Director

18.11K

+98.39%

Ms. Regina E. (Reggie) Groves

Independent Director

12.23K

+276.37%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Insurance

41.32M

56.25%

Institutional

30.74M

41.85%

Patient

1.40M

1.90%

地區USD

名稱

營收

佔比

United States

67.83M

92.33%

Foreign

5.64M

7.67%

業務

地區

業務USD

名稱

營收

佔比

Insurance

41.32M

56.25%

Institutional

30.74M

41.85%

Patient

1.40M

1.90%

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

Hsieh (Ming)

28.80%

BlackRock Institutional Trust Company, N.A.

5.55%

Millennium Management LLC

4.74%

The Vanguard Group, Inc.

3.83%

Dimensional Fund Advisors, L.P.

3.38%

Other

53.70%

持股股東

佔比

Hsieh (Ming)

28.80%

BlackRock Institutional Trust Company, N.A.

5.55%

Millennium Management LLC

4.74%

The Vanguard Group, Inc.

3.83%

Dimensional Fund Advisors, L.P.

3.38%

Other

53.70%

股東類型

持股股東

佔比

Individual Investor

33.39%

Investment Advisor/Hedge Fund

17.42%

Investment Advisor

17.28%

Hedge Fund

16.03%

Research Firm

3.25%

Bank and Trust

0.45%

Pension Fund

0.26%

Venture Capital

0.06%

Insurance Company

0.02%

Other

11.83%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

462

26.90M

88.35%

-2.94M

2025Q1

479

26.79M

87.53%

-3.17M

2024Q4

478

27.37M

89.05%

-1.51M

2024Q3

495

26.29M

86.76%

-1.76M

2024Q2

531

25.43M

84.95%

-2.34M

2024Q1

552

25.03M

83.71%

-1.71M

2023Q4

583

24.11M

81.35%

-2.57M

2023Q3

588

24.06M

80.39%

-2.54M

2023Q2

592

23.63M

79.58%

-3.71M

2023Q1

620

23.53M

79.25%

-3.02M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Hsieh (Ming)

8.77M

28.8%

-6.40K

-0.07%

May 26, 2025

BlackRock Institutional Trust Company, N.A.

1.69M

5.55%

-1.55M

-47.88%

Mar 31, 2025

Millennium Management LLC

1.97M

6.47%

+437.63K

+28.57%

Mar 31, 2025

The Vanguard Group, Inc.

1.16M

3.83%

-223.10K

-16.07%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.03M

3.38%

-16.82K

-1.61%

Mar 31, 2025

Gao (Hanlin)

877.95K

2.88%

-754.00

-0.09%

Jun 02, 2025

Acadian Asset Management LLC

805.94K

2.65%

+446.08K

+123.96%

Mar 31, 2025

Columbia Threadneedle Investments (US)

625.30K

2.05%

+123.49K

+24.61%

Mar 31, 2025

State Street Global Advisors (US)

506.79K

1.66%

-312.64K

-38.15%

Mar 31, 2025

Geode Capital Management, L.L.C.

505.24K

1.66%

-8.91K

-1.73%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

SPDR S&P Health Care Services ETF

0.84%

Global X Genomics & Biotechnology ETF

0.51%

ALPS Medical Breakthroughs ETF

0.41%

iShares US Small Cap Value Factor ETF

0.28%

iShares MSCI USA Small-Cap Min Vol Factor ETF

0.07%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.06%

iShares U.S. Healthcare Providers ETF

0.06%

Invesco RAFI US 1500 Small-Mid ETF

0.05%

Avantis US Small Cap Equity ETF

0.05%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.05%

SPDR S&P Health Care Services ETF

佔比0.84%

Global X Genomics & Biotechnology ETF

佔比0.51%

ALPS Medical Breakthroughs ETF

佔比0.41%

iShares US Small Cap Value Factor ETF

佔比0.28%

iShares MSCI USA Small-Cap Min Vol Factor ETF

佔比0.07%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

佔比0.06%

iShares U.S. Healthcare Providers ETF

佔比0.06%

Invesco RAFI US 1500 Small-Mid ETF

佔比0.05%

Avantis US Small Cap Equity ETF

佔比0.05%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.05%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

KeyAI

